[1]
“Conversion Therapy for Advanced Hepatocellular Carcinoma Following Complete Response to Transarterial Radioembolization Combined with Atezolizumab and Bevacizumab”, Radiol Oncol, vol. 60, no. 1, pp. 40–48, Mar. 2026, Accessed: Oct. 22, 2026. Available: https://radioloncol.com/index.php/ro/article/view/4783